110 related articles for article (PubMed ID: 1277191)
1. Prolonged tumor dormancy by prevention of neovascularization in the vitreous.
Brem S; Brem H; Folkman J; Finkelstein D; Patz A
Cancer Res; 1976 Aug; 36(8):2807-12. PubMed ID: 1277191
[TBL] [Abstract][Full Text] [Related]
2. Components of vitreous-soluble proteins: effect of hyperoxia and age.
Chen CH; Patz A
Invest Ophthalmol; 1976 Mar; 15(3):228-32. PubMed ID: 1254412
[TBL] [Abstract][Full Text] [Related]
3. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
Gu X; Samuel S; El-Shabrawey M; Caldwell RB; Bartoli M; Marcus DM; Brooks SE
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):496-502. PubMed ID: 11818396
[TBL] [Abstract][Full Text] [Related]
4. The role of vascular proliferation in the growth of brain tumors.
Brem S
Clin Neurosurg; 1976; 23():440-53. PubMed ID: 975695
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
6. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
7. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).
Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999
[TBL] [Abstract][Full Text] [Related]
9. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
[TBL] [Abstract][Full Text] [Related]
10. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT
Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654
[TBL] [Abstract][Full Text] [Related]
11. A new approach to the problem of retinal neovascularization.
Patz A; Brem S; Finkelstein D; Chen CH; Lutty G; Bennett A; Coughlin WR; Gardner J
Ophthalmology; 1978 Jun; 85(6):626-37. PubMed ID: 580956
[TBL] [Abstract][Full Text] [Related]
12. Histopathology of experimental preretinal neovascularization.
de Juan E; Humayun MS; Hatchell DL; Wilson D
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1495-503. PubMed ID: 2473045
[TBL] [Abstract][Full Text] [Related]
13. Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma.
Levine HA; Pamuk S; Sleeman BD; Nilsen-Hamilton M
Bull Math Biol; 2001 Sep; 63(5):801-63. PubMed ID: 11565406
[TBL] [Abstract][Full Text] [Related]
14. Vitreous inhibition of tumor neovascularization.
Felton SM; Brown GC; Felberg NT; Federman JL
Arch Ophthalmol; 1979 Sep; 97(9):1710-3. PubMed ID: 475643
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of neovascularization in relation to diabetic and other proliferative retinopathies.
Patz A; Lutty G; Bennett A; Coughlin WR
Trans Am Ophthalmol Soc; 1978; 76():102-7. PubMed ID: 754366
[TBL] [Abstract][Full Text] [Related]
16. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
[TBL] [Abstract][Full Text] [Related]
17. [TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy].
Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A
Med Klin (Munich); 1995 Mar; 90(3):134-7. PubMed ID: 7723714
[TBL] [Abstract][Full Text] [Related]
18. [The current data on the proliferative process in diabetic retinopathy].
Mazurina NK
Vestn Oftalmol; 1999; 115(3):37-40. PubMed ID: 10432854
[No Abstract] [Full Text] [Related]
19. Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy.
Cohen MP; Hud E; Shea E; Shearman CW
Ophthalmic Res; 2008; 40(1):5-9. PubMed ID: 18025835
[TBL] [Abstract][Full Text] [Related]
20. Vitreous: an inhibitor of retinal extract-induced neovascularization.
Lutty GA; Thompson DC; Gallup JY; Mello RJ; Patz A; Fenselau A
Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):52-6. PubMed ID: 6186631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
